Literature DB >> 18408620

Curing the cure: utilizing exercise to limit cardiotoxicity.

Craig A Emter1, Douglas K Bowles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18408620      PMCID： PMC2651002          DOI： 10.1249/MSS.0b013e3181684d03

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN： 0195-9131            Impact factor:   5.411


× No keyword cloud information.
  9 in total

1.  Myosin heavy chain isoform expression in the failing and nonfailing human heart.

Authors:  S Miyata; W Minobe; M R Bristow; L A Leinwand
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

2.  Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression.

Authors:  T J Herron; F S Korte; K S McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

3.  Sarcomere length dependence of rat skinned cardiac myocyte mechanical properties: dependence on myosin heavy chain.

Authors:  F Steven Korte; Kerry S McDonald
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

4.  Doxorubicin impairs crossbridge turnover kinetics in skinned cardiac trabeculae after acute and chronic treatment.

Authors:  E L de Beer; A E Bottone; J van Der Velden; E E Voest
Journal:  Mol Pharmacol       Date:  2000-06       Impact factor: 4.436

5.  Power output is linearly related to MyHC content in rat skinned myocytes and isolated working hearts.

Authors:  F Steven Korte; Todd J Herron; Michael J Rovetto; Kerry S McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-03-25       Impact factor: 4.733

6.  Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity.

Authors:  Adam J Chicco; David S Hydock; Carole M Schneider; Reid Hayward
Journal:  J Appl Physiol (1985)       Date:  2005-10-06

7.  Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects.

Authors:  J C Tardiff; T E Hewett; S M Factor; K L Vikstrom; J Robbins; L A Leinwand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-02       Impact factor: 4.733

8.  Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.

Authors:  David S Hydock; Chia-Ying Lien; Carole M Schneider; Reid Hayward
Journal:  Med Sci Sports Exerc       Date:  2008-05       Impact factor: 5.411

9.  The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals.

Authors:  D Irvine; L Vincent; J E Graydon; N Bubela; L Thompson
Journal:  Cancer Nurs       Date:  1994-10       Impact factor: 2.592
  9 in total
  4 in total

1.  Overweight female rats selectively breed for low aerobic capacity exhibit increased myocardial fibrosis and diastolic dysfunction.

Authors:  Vincent G DeMarco; Megan S Johnson; Lixin Ma; Lakshmi Pulakat; Irina Mugerfeld; Melvin R Hayden; Mona Garro; William Knight; Steven L Britton; Lauren G Koch; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-17       Impact factor: 4.733

2.  Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Robin M Lally; Terry S Langbaum; Allison L McDonough; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; William Pirl; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2018-10       Impact factor: 11.908

Review 3.  Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity.

Authors:  Dong-Woo Kang; Rebekah L Wilson; Cami N Christopher; Amber J Normann; Oscar Barnes; Jordan D Lesansee; Gyuhwan Choi; Christina M Dieli-Conwright
Journal:  Front Cardiovasc Med       Date:  2022-01-14

Review 4.  Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors.

Authors:  Amy A Kirkham; Margot K Davis
Journal:  J Oncol       Date:  2015-08-03       Impact factor: 4.375
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.